Urinary metabolite signature in bipolar disorder patients during depressive episode

scientific article published on 01 February 2019

Urinary metabolite signature in bipolar disorder patients during depressive episode is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.18632/AGING.101805
P932PMC publication ID6382435
P698PubMed publication ID30721880

P50authorJian-Jun ChenQ89628907
P2093author name stringJing Xie
Peng Xie
Li Zeng
Peng Zheng
Chan-Juan Zhou
P2860cites workThe impact of environmental factors in severe psychiatric disordersQ21129355
The human urine metabolomeQ21132532
The Neurobiology of the Switch Process in Bipolar DisorderQ22241114
Strategies to Reduce Misdiagnosis of Bipolar DepressionQ22241851
Bipolar disorderQ22242063
Differentiating Bipolar Disorders from Major Depressive Disorders: Treatment ImplicationsQ22248025
The genetics of bipolar disorderQ22251249
Innate immunity and intestinal microbiota in the development of Type 1 diabetesQ24647312
Gut microbiota from twins discordant for obesity modulate metabolism in miceQ29614796
The impact of the gut microbiota on human health: an integrative viewQ29617446
Central nervous system regulation of eating: Insights from human brain imagingQ31079099
Mitochondrial protein Fus1/Tusc2 in premature aging and age-related pathologies: critical roles of calcium and energy homeostasisQ33563545
Neurobiology of food intake in health and diseaseQ33825213
Principles and practical application of the receiver-operating characteristic analysis for diagnostic tests.Q33913309
The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in miceQ34193512
The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent mannerQ34300369
Treatment of the depressive phase of bipolar affective disorder: a reviewQ34360864
The genetics of schizophrenia and bipolar disorder: dissecting psychosisQ34555635
Hypothalamic-pituitary-adrenal axis dysfunction and illness progression in bipolar disorder.Q35203604
Combined Metabolomics and Proteomics Analysis of Major Depression in an Animal Model: Perturbed Energy Metabolism in the Chronic Mild Stressed Rat Cerebellum.Q35861541
Hypothalamic-pituitary-adrenal axis and bipolar disorder.Q36096503
Identification and validation of urinary metabolite biomarkers for major depressive disorderQ36508139
Prospective studies of suicidal behavior in major depressive and bipolar disorders: what is the evidence for predictive risk factors?Q36556737
Metabonomics study of essential hypertension and its chinese medicine subtypes by using gas chromatography-mass spectrometry and nuclear magnetic resonance spectroscopyQ36682631
Identification of sex-specific urinary biomarkers for major depressive disorder by combined application of NMR- and GC-MS-based metabonomicsQ37648213
Combined application of NMR- and GC-MS-based metabonomics yields a superior urinary biomarker panel for bipolar disorder.Q37733240
Social cognition and the manic defense: attributions, selective attention, and self-schema in bipolar affective disorderQ38449392
Differential urinary metabolites related with the severity of major depressive disorderQ38669894
Divergent Urinary Metabolic Phenotypes between Major Depressive Disorder and Bipolar Disorder Identified by a Combined GC-MS and NMR Spectroscopic Metabonomic ApproachQ38985361
Effects of gut microbiota on the microRNA and mRNA expression in the hippocampus of mice.Q39017815
Chronic exercise reduces hypothalamic transforming growth factor-β1 in middle-aged obese miceQ41669849
Attentional biases toward emotional images in the different episodes of bipolar disorder: an eye-tracking study.Q44124943
Evaluation of the orthogonal projection on latent structure model limitations caused by chemical shift variability and improved visualization of biomarker changes in 1H NMR spectroscopic metabonomic studies.Q45222765
Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host's metabolismQ46565524
Metabonomic analysis identifies molecular changes associated with the pathophysiology and drug treatment of bipolar disorderQ46767416
Review and Meta-Analysis of Epidemiologic Studies of Adult Bipolar DisorderQ47393233
Serum phosphatidylinositol as a biomarker for bipolar disorder liabilityQ48203863
Serum brain-derived neurotrophic factor is decreased in bipolar disorder during depressive and manic episodes.Q48649203
2,4-Dihydroxypyrimidine is a potential urinary metabolite biomarker for diagnosing bipolar disorder.Q50663896
Sex differences in gut microbiota in patients with major depressive disorder.Q52665670
Integrative analysis of gut microbiota composition, host colonic gene expression and intraluminal metabolites in aging C57BL/6J mice.Q55242726
Urinary biomarker panel for diagnosing patients with depression and anxiety disordersQ57155162
GC-MS-based metabolomics approach to diagnose depression in hepatitis B virus-infected patients with middle or old ageQ57161916
Altered brain energy metabolism in lithium-resistant bipolar disorder detected by photic stimulated 31P-MR spectroscopyQ73560007
Bipolar disorderQ77549686
A multi-analytical platform approach to the metabonomic analysis of plasma from normal and Zucker (fa/fa) obese ratsQ80037913
Abnormal gut microbiota composition contributes to cognitive dysfunction in SAMP8 miceQ89052650
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectbipolar disorderQ131755
P304page(s)1008-1018
P577publication date2019-02-01
P1433published inAgingQ2845875
P1476titleUrinary metabolite signature in bipolar disorder patients during depressive episode
P478volume11

Reverse relations

cites work (P2860)
Q89628910Age-specific differential changes on gut microbiota composition in patients with major depressive disorder
Q93167649Age-specific urinary metabolite signatures and functions in patients with major depressive disorder
Q90371599Circulating microRNA 134 sheds light on the diagnosis of major depressive disorder
Q90353598Efficacy of ginkgo biloba extract as augmentation of venlafaxine in treating post-stroke depression
Q99403576Identification of Potential Metabolite Markers for Middle-Aged Patients with Post-Stroke Depression Using Urine Metabolomics
Q64104741Short-term efficacy and safety of repaglinide versus glimepiride as augmentation of metformin in treating patients with type 2 diabetes mellitus
Q93185341Urinary biomarkers for diagnosing poststroke depression in patients with type 2 diabetes mellitus
Q113881439Verbal learning, working memory, and attention/vigilance may be candidate phenotypes of bipolar II depression in Chinese Han nationality

Search more.